Two Sigma Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History

Two Sigma Advisers’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$52K	–	2520
2019 Q2	$52K	Buy	+10,000	New	+$44.9K	﹤0.01%	2252
2016 Q4	–	Sell	-11,500	Closed	-$108K	–	2507
2016 Q3	$108K	Buy	+11,500	New	+$95.5K	﹤0.01%	2130

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Two Sigma Advisers's PETX Position: Q3 2019 in Review

Two Sigma Advisers sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,000 shares — an estimated $52K sold.

Two Sigma Advisers first reported a position in PETX in Q3 2016 and held it in 2 quarters. The position peaked at $108K in Q3 2016. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Two Sigma Advisers reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Two Sigma Advisers sold 10,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
Two Sigma Advisers first reported a position in Aratana Therapeutics, Inc. in Q3 2016 and held it in 2 quarters.
Two Sigma Advisers's Aratana Therapeutics, Inc. position peaked at $108K in Q3 2016.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Two Sigma Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.